Lexicon Pharmaceuticals Inc

Summary

Introduction

Lexicon Pharmaceuticals is a biopharmaceutical company focused on clinical development in the areas of irritable bowel syndrome, cognitive disorders, autoimmune diseases, and carcinoid syndrome. The company uses its proprietary gene knockout technology which has enabled to discover more than 100 promising drug targets and create an extensive pipeline of clinical and preclinical programs.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Lexicon Pharmaceuticals' lead candidate is LX6171, a Phase II candidate being developed as a potential treatment for cognitive impairment associated with disorders such as Alzheimer's disease, schizophrenia and vascular dementia. Lexicon Pharmaceuticals derives its revenues from collaboration agreements associated with the company's drug discovery alliances with Genentech, Takeda and Bristol-Myers Squibb for the research, development and commercialization of small molecule and new biotherapeutic drugs. The company's sole contributor to total revenues out to 2010 would be license, collaboration and other revenues earned in connection with the company's drug discovery alliances with Genentech, Takeda and Bristol-Myers Squibb for the research, development and commercialization of small molecule and new biotherapeutic drugs.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization .

Contents

• Overview
• Catalyst
• Summary
  • Company Structure
  • Company Overview and Key Facts
  • Business Description
  • History
  • Locations and Subsidiaries
  • Company Financials
  • Stock Market Performance
  • P&l
  • Balance Sheet
  • Cash Flow
  • Products & Services
  • Pipeline Products
  • Ac Forecast Product Sales
  • Competitors and Strategic Business Relationships
  • Top Competitors
  • Key Suppliers
  • Key Clients
  • Shareholding Structure
  • Strategy
  • Company View
  • Corporate Strategy
  • SWOT Analysis
  • Overview
  • Strengths
  • Weaknesses
  • Opportunities
  • Threats
  • Value Chain Analysis
  • Overview
  • Discovery and Product Development
  • Scorecard
  • Overview
  • Scorecard Analysis
  • Key Employees
  • List of Key Employees
  • Key Employee Biographies
  • Financial and Operational Overview
  • Financial and Operational Overview
  • Appendix
  • Ask The Analyst
  • Datamonitor Consulting
  • Disclaimer
• Table of Figures
  • Figure 1: Lexicon Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
• Table of Tables
  • Table 1: Lexicon Pharmaceuticals - Key Facts
  • Table 2: Lexicon Pharmaceuticals - Other Locations and Subsidiaries
  • Table 3: Lexicon Pharmaceuticals - Year-End Share Price and Market Capitalization, 2002-2006 ($)
  • Table 4: Lexicon Pharmaceuticals - Key Events Impacting Share Price Performance
  • Table 5: Lexicon Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
  • Table 6: Lexicon Pharmaceuticals - Operating Cost Ratio Analysis, 2002-2006 (% of Total Revenues)
  • Table 7: Lexicon Pharmaceuticals - Balance Sheet, 2002-2006 ($ Mn)
  • Table 8: Lexicon Pharmaceuticals - Cash Flow, 2002-2006 ($ Mn)
  • Table 9: Lexicon Pharmaceuticals - in-House Pipeline Products
  • Table 10: Lexicon Pharmaceuticals - Collaboration Pipeline Products
  • Table 11: Lexicon Pharmaceuticals - Forecast Sales, 2006-2010 ($ Mn)
  • Table 12: Lexicon Pharmaceuticals - Top Competitors
  • Table 13: Lexicon Pharmaceuticals - Key Suppliers
  • Table 14: Lexicon Pharmaceuticals - Key Clients
  • Table 15: Lexicon Pharmaceuticals - Key Shareholders
  • Table 16: Lexicon Pharmaceuticals - SWOT Analysis Summary
  • Table 17: Lexicon Pharmaceuticals - Value Chain Analysis
  • Table 18: Lexicon Pharmaceuticals - Scorecard
  • Table 19: Lexicon Pharmaceuticals - Key Employees
  • Table 20: Lexicon Pharmaceuticals - Financial and Operational Overview